
Faslodex (fulvestrant) is an estrogen receptor antagonist indicated for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. Each prefilled syringe delivers 250 mg of fulvestrant in 5 mL of solution for intramuscular injection. Supplied as a package of 2 prefilled syringes.
Sorted by lowest price · Add now, sign in at checkout


Sorted by lowest price · Add now, sign in at checkout

Faslodex (fulvestrant) is an estrogen receptor antagonist indicated for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. Each prefilled syringe delivers 250 mg of fulvestrant in 5 mL of solution for intramuscular injection. Supplied as a package of 2 prefilled syringes.
1 vendor
Products you might be interested in